Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

Measles viruses derived from the live-attenuated Edmonton-B vaccine lineage are currently investigated as novel anti-cancer therapeutics. In this context, tumor specificity and oncolytic potency are key determinants of the therapeutic index. Here, we describe a systematic and comprehensive analysis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Oncolytics
Autores principales: Leber, Mathias Felix, Baertsch, Marc-Andrea, Anker, Sophie Caroline, Henkel, Luisa, Singh, Hans Martin, Bossow, Sascha, Engeland, Christine E., Barkley, Russell, Hoyler, Birgit, Albert, Jessica, Springfeld, Christoph, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026446/
https://ncbi.nlm.nih.gov/pubmed/29988512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2018.04.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares